Portola Pharmaceuticals, Inc. Discovering and developing novel therapeutics.
Selskapet beskrivelse:
portola pharmaceuticals is a biopharmaceutical company developing innovative drugs for the treatment of cardiovascular and inflammatory diseases portolaõs two most advanced programs are in phase ii clinical trials: 1) betrixaban, an oral, once-daily factor xa inhibitor being developed for stroke prevention in patients with atrial fibrillation (spaf) and for prevention of venous thromboembolism (vte) in various patient populations, and 2) elinogrel, a direct-acting, reversible oral and i.v. adp receptor antagonist initially being developed for patients with acute coronary syndrome (acs).
Nøkkelord for å søke:
biopharmaceutical company, innovative drugs, treatment of cardiovascular diseases, inflammatory diseases, betrixaban, factor xa inhibitor, stroke prevention, atrial fibrillation, prevention of venous thromboembolism, elinogrel, oral and i.v. adp receptor antagonist, acute coronary syndrome, antithrombotic, thrombosis, inflammatory diseases
Firma Adresse :
4941 Page Ave,MICHIGAN CENTER,MI,USA
ZIP Code: Postnummer :
49254-1156
Telefonnummer :
5177640973 (+1-517-764-0973)
Faksnummer :
5177645554 (+1-517-764-5554)
Nettside :
www. portola. com
e-post :
USA SIC kode ( Standard for næringsgruppering Code):
kopiere og lime inn denne google map til din nettside eller blogg!
Trykk på knappen kopiere og lime inn i din blogg eller nettside.
(Du kan bytte til HTML -modus når du legger inn din blogg. Examples: WordPress Example, Blogger Example)
Kontakt denne potensielle forhandler , kjøper, selger , leverandør , produsent , eksportør , importør
(Input kjøp , selg , sitere for produkter eller tjenester)